Distinct Markers of Discordant Treatment Response to Lifestyle Intervention in MASLD, Independent of Weight Loss
<b>Background/Objectives:</b> Weight loss is the primary therapy for metabolic dysfunction-associated steatotic liver disease (MASLD). However, the proportion and factors influencing therapeutic changes in the liver condition contrary to weight loss remain unclear. <b>Methods</b>: This observational...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2025-09-01
|
| Серии: | Biomedicines |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/2227-9059/13/9/2161 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|